Ratings Thai NVDR Co., Ltd.

Equities

KLINIQ

THB058010000

End-of-day quote Thailand S.E. 06:00:00 2024-07-10 pm EDT 5-day change 1st Jan Change
41.5 THB -1.19% Intraday chart for Thai NVDR Co., Ltd. +1.22% -1.19%

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

  • With a 2024 P/E ratio at 25.36 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
  • The company appears highly valued given the size of its balance sheet.
  • The company is highly valued given the cash flows generated by its activity.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
-1.19% 254M -
-31.29% 12.6B
B+
+5.14% 11.8B
B+
-5.41% 11.48B
B
+12.01% 10.98B
B+
+28.75% 8.54B
B
+18.63% 7.36B
B-
-10.66% 7.22B
A-
+7.33% 6.54B
D
0.00% 4.44B - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
-
  1. Stock Market
  2. Equities
  3. KLINIQ Stock
  4. Ratings Thai NVDR Co., Ltd.